Virtus ETF Advisers’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-18,897
| Closed | -$1.61M | – | 368 |
|
|
2020
Q3 | $1.61M | Buy |
18,897
+1,592
| +9% | +$80.5K | 0.84% | 2 |
|
|
2020
Q2 | $613K | Sell |
17,305
-92
| -0.5% | -$2.69K | 0.29% | 112 |
|
|
2020
Q1 | $235K | Sell |
17,397
-2,528
| -13% | -$42.5K | 0.1% | 261 |
|
|
2019
Q4 | $422K | Sell |
19,925
-523
| -3% | -$9.23K | 0.07% | 241 |
|
|
2019
Q3 | $271K | Sell |
20,448
-1,139
| -5% | -$16.7K | 0.05% | 206 |
|
|
2019
Q2 | $299K | Buy |
+21,587
| New | +$325K | 0.06% | 215 |
|
|
2019
Q1 | – | Sell |
-15,848
| Closed | -$226K | – | 293 |
|
|
2018
Q4 | $226K | Sell |
15,848
-3,818
| -19% | -$75.8K | 0.04% | 171 |
|
|
2018
Q3 | $410K | Sell |
19,666
-14,095
| -42% | -$334K | 0.04% | 159 |
|
|
2018
Q2 | $799K | Sell |
33,761
-26,601
| -44% | -$535K | 0.71% | 27 |
|
|
2018
Q1 | $882K | Buy |
60,362
+32,166
| +114% | +$526K | 0.77% | 62 |
|
|
2017
Q4 | $456K | Sell |
28,196
-14,588
| -34% | -$172K | 0.57% | 45 |
|
|
2017
Q3 | $598K | Buy |
42,784
+3,913
| +10% | +$39K | 0.08% | 79 |
|
|
2017
Q2 | $343K | Sell |
38,871
-36,163
| -48% | -$254K | 0.05% | 90 |
|
|
2017
Q1 | $485K | Buy |
75,034
+7,193
| +11% | +$36.4K | 0.09% | 103 |
|
|
2016
Q4 | $249K | Sell |
67,841
-13,169
| -16% | -$39K | 0.07% | 145 |
|
|
2016
Q3 | $263K | Hold |
81,010
| – | – | 0.13% | 119 |
|
|
2016
Q2 | $188K | Sell |
81,010
-6,052
| -7% | -$20.2K | 0.14% | 139 |
|
|
2016
Q1 | $218K | Sell |
87,062
-5,418
| -6% | -$12.2K | 0.3% | 73 |
|
|
2015
Q4 | $284K | Buy |
+92,480
| New | +$258K | 0.78% | 43 |
|
Virtus ETF Advisers's IMMU Position: Q4 2020 in Review
Virtus ETF Advisers sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 18,897 shares — an estimated $1.61M sold.
Virtus ETF Advisers first reported a position in IMMU in Q4 2015 and held it in 19 quarters. The position peaked at $1.61M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Virtus ETF Advisers reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Virtus ETF Advisers sold 18,897 Immunomedics Inc shares in Q4 2020, an estimated $1.61M.
- Virtus ETF Advisers first reported a position in Immunomedics Inc in Q4 2015 and held it in 19 quarters.
- Virtus ETF Advisers's Immunomedics Inc position peaked at $1.61M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Virtus ETF Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.